Comparison of the clinical characteristics and imaging findings of Acute cholangitis with and without biliary dilatation
Executive Summary
This briefing document synthesizes the findings of a retrospective study analyzing the clinical characteristics and imaging findings of 93 patients diagnosed with acute cholangitis. The study differentiates between patients presenting with biliary dilatation (the majority) and those presenting without it.
Critical takeaways include:
Presence Without Dilatation: Approximately 18% of acute cholangitis cases presented without biliary dilatation on CT scans.
Primary Etiology: Common bile duct (CBD) stones and sludge are the most frequent causes in patients without dilatation. Malignancies were found exclusively in patients with biliary dilatation.
Laboratory Divergence: Patients without dilatation (Group 1) exhibited significantly lower total bilirubin levels but higher median alanine aminotransferase (ALT) levels compared to those with dilatation (Group 2).
Imaging Discriminators: While transient hepatic attenuation differences (THADs) were common in both groups, the extent of THAD involvement (the number of liver segments affected) was the only significant CT finding that discriminated between the two groups.
Clinical Outcomes: Patients without biliary dilatation generally required shorter hospital stays than those with dilatation.
Study Overview and Methodology
The study evaluated 93 patients diagnosed with acute cholangitis based on the Tokyo Guidelines (2006). These patients underwent contrast-enhanced dynamic CT scans.
Patient Classification
Group 1 (n=17): Patients without biliary dilatation.
Group 2 (n=76): Patients with biliary dilatation.
Demographics: The study population consisted of 59 males and 34 females with a mean age of 68 years.
Diagnostic Criteria
Diagnosis was confirmed through:
Charcot’s triad: Fever/chills, jaundice, and abdominal pain.
Laboratory Data: Evidence of inflammatory response (WBC count, CRP) and abnormal liver function tests.
Imaging Findings: Biliary dilatation or evidence of etiology (stones, strictures).
Etiology and Causative Factors
The study identified distinct patterns in the underlying causes of cholangitis based on the presence or absence of ductal dilatation.
Key Observations on Etiology
Malignancy: All 27 cases involving biliary or peribiliary malignancies (including cholangiocarcinoma and pancreatic cancer) presented with biliary dilatation. The high degree of obstruction caused by solid tumor masses facilitates ductal expansion.
Stones and Sludge: These were the most common causes for Group 1. The study suggests that smaller stones (often <8 mm) or sludge may not cause enough obstruction to result in visible dilatation but are sufficient to cause infection.
Stone Size: The diameter of stones was significantly larger in Group 2 (mean 12.63 mm) than in Group 1 (mean 5.58 mm).
Comparison of Clinical and Laboratory Findings
The clinical presentation of acute cholangitis varies significantly depending on whether the bile ducts are dilated.
Laboratory Data Comparison
The study found statistically significant differences in liver function tests:
Total Bilirubin: Group 2 (8.53 mg/dl) was significantly higher than Group 1 (4.58 mg/dl). This is attributed to more complete and prolonged obstruction in Group 2, particularly in malignant cases.
ALT (Alanine Aminotransferase): Group 1 (256.71 IU/l) showed significantly higher levels than Group 2 (170.19 IU/l). High transaminase levels are sensitive indicators of acute hepatocellular damage, often seen in acute biliary stone disease or stone passage.
WBC Count: While Group 2 had higher counts (14,245 vs 11,596 cells/ml), the difference was on the threshold of statistical significance (p=0.052).
Clinical Outcomes
Hospital Stay: Group 2 patients required a significantly longer stay (mean 16.99 days) compared to Group 1 (8.12 days).
Invasive Treatment: There was no significant difference in the requirement for invasive procedures (endoscopic drainage, stone removal) between the groups, with high rates in both (82% for Group 1, 88% for Group 2).
Imaging and Radiologic Analysis
The primary objective of imaging analysis was to identify CT markers that could differentiate between the two groups beyond the presence of dilatation itself.
Transient Hepatic Attenuation Differences (THADs)
THADs are areas of high attenuation on arterial phase images that return to isoattenuation on portal venous phase images. They result from increased arterial blood supply as a compensatory reaction to decreased portal flow.
Incidence: THADs were present in 90% of all patients.
Extent: This was the only significant discriminative CT finding. Group 2 showed involvement across significantly more liver segments (mean 7.69 segments) than Group 1 (mean 4.49 segments).
Mechanism: Biliary dilatation causes the collapse of the peribiliary plexus. This collapse reduces blood flow from the portal vein into the sinusoids, triggering a larger arterial compensatory response (THAD) across the liver.
Other Imaging Findings
No significant differences were found between the two groups regarding:
Periportal tracking.
Perihepatic lymphadenopathy.
Wall thickening of the extrahepatic duct.
Longest transverse diameter of the gallbladder.
Pathophysiological Considerations
The study highlights that biliary obstruction and acute cholangitis can exist prior to the development of biliary dilatation.
Intraductal Pressure: Increase in pressure results from obstruction. High pressure leads to cholangiovenous or cholangiolymphatic reflux, potentially resulting in systemic inflammatory response syndrome.
Reflux and Severity: While it was hypothesized that Group 2 would show more severe cholangitis due to higher pressure, the study found that both groups required high levels of invasive intervention.
Physiological Adaptation: The study suggests that patients in Group 2 (especially those with malignancies or large stones) may have more prolonged obstruction, allowing the bile duct to adapt and dilate. In contrast, Group 1 may represent more acute, fluctuating obstruction (e.g., small stones or sludge) where transaminase levels spike due to acute liver cell injury before dilatation can occur.
Conclusion
Acute cholangitis without biliary dilatation is a distinct clinical subset primarily caused by CBD stones and sludge. These patients present with a biochemical profile characterized by lower bilirubin and higher ALT levels compared to patients with biliary dilatation. While CT findings are largely similar between both groups, the extent of hepatic THAD involvement serves as a key indicator of the presence and severity of biliary dilatation and infection. Awareness of these differences is essential for the timely diagnosis and management of patients who do not meet the traditional imaging criteria of ductal dilatation.
